CD4+ T cells are required to improve the efficacy of CIK therapy in non-small cell lung cancer
2022 · Cell Death and Disease · 42 citations
https://doi.org/10.1038/s41419-022-04882-x
Jimei University(CN)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
14
Papers
158
Citations
5
h-index
3
i10-index
Yingge Lv is an academic researcher from Jimei University. The author has contributed to research in topics: Cancer Immunotherapy and Biomarkers & Lung Cancer Treatments and Mutations & Immune Cell Function and Interaction. The author has an h-index of 5, co-authored 12 publications.
https://doi.org/10.1038/s41419-022-04882-x
https://doi.org/10.1186/s12885-024-13084-x
Click to start Chat